Sachs JR - Search Results

1

Elucidating vaccine efficacy using a correlate of protection, demographics, and logistic regression.

Dudášová J, Valenta Z, Sachs JR. Dudášová J, et al. Among authors: sachs jr. BMC Med Res Methodol. 2024 Apr 30;24(1):101. doi: 10.1186/s12874-024-02197-3. BMC Med Res Methodol. 2024. PMID: 38689224 Free PMC article.

2

A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data.

Dudášová J, Laube R, Valiathan C, Wiener MC, Gheyas F, Fišer P, Ivanauskaite J, Liu F, Sachs JR. Dudášová J, et al. Among authors: sachs jr. NPJ Vaccines. 2021 Nov 4;6(1):133. doi: 10.1038/s41541-021-00377-6. NPJ Vaccines. 2021. PMID: 34737322 Free PMC article.

3

Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines.

Rosenbloom DIS, Dudášová J, Davis C, Railkar RA, Mehrotra N, Sachs JR. Rosenbloom DIS, et al. Among authors: sachs jr. Vaccines (Basel). 2023 Sep 19;11(9):1501. doi: 10.3390/vaccines11091501. Vaccines (Basel). 2023. PMID: 37766177 Free PMC article.

4

Improving precision of vaccine efficacy evaluation using immune correlate data in time-to-event models.

Dudášová J, Valenta Z, Sachs JR. Dudášová J, et al. Among authors: sachs jr. NPJ Vaccines. 2024 Nov 11;9(1):214. doi: 10.1038/s41541-024-00937-6. NPJ Vaccines. 2024. PMID: 39528514 Free PMC article.

5

V² ACHER: Visualization of complex trial data in pharmacometric analyses with covariates.

Lommerse J, Plock N, Cheung SYA, Sachs JR. Lommerse J, et al. Among authors: sachs jr. CPT Pharmacometrics Syst Pharmacol. 2021 Sep;10(9):1092-1106. doi: 10.1002/psp4.12679. Epub 2021 Aug 6. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34242494 Free PMC article.

6

Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children.

Ryman J, Weaver J, Yee KL, Sachs JR. Ryman J, et al. Among authors: sachs jr. Expert Rev Vaccines. 2022 Oct;21(10):1515-1521. doi: 10.1080/14760584.2022.2112179. Epub 2022 Aug 25. Expert Rev Vaccines. 2022. PMID: 35997125 Free article.

7

Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach.

Kandala B, Plock N, Chawla A, Largajolli A, Robey S, Watson K, Thatavarti R, Dubey SA, Cheung SYA, de Greef R, Stone J, Sachs JR. Kandala B, et al. Among authors: sachs jr. EBioMedicine. 2022 Oct;84:104264. doi: 10.1016/j.ebiom.2022.104264. Epub 2022 Sep 28. EBioMedicine. 2022. PMID: 36182824 Free PMC article.

8

Model Informed Drug Development: Novel Oncology Agents are Lost in Translation.

Mayawala K, de Alwis DP, Sachs JR. Mayawala K, et al. Among authors: sachs jr. Clin Cancer Res. 2019 Nov 15;25(22):6564-6566. doi: 10.1158/1078-0432.CCR-19-2482. Epub 2019 Sep 12. Clin Cancer Res. 2019. PMID: 31515459

9

Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data.

Ryman J, Weaver J, Hu T, Weinberger DM, Yee KL, Sachs JR. Ryman J, et al. Among authors: sachs jr. NPJ Vaccines. 2022 Nov 7;7(1):140. doi: 10.1038/s41541-022-00538-1. NPJ Vaccines. 2022. PMID: 36344529 Free PMC article.

10

Optimal Dosing for Targeted Therapies in Oncology: Drug Development Cases Leading by Example.

Sachs JR, Mayawala K, Gadamsetty S, Kang SP, de Alwis DP. Sachs JR, et al. Clin Cancer Res. 2016 Mar 15;22(6):1318-24. doi: 10.1158/1078-0432.CCR-15-1295. Epub 2015 Nov 23. Clin Cancer Res. 2016. PMID: 26597302 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters